Rare diseases | pharmaphorum

Monday 25 November 2024

Channels

Content type

Categories

Categories

Sort by

Order

Rare diseases

Events

26323 Pharma Phorum Banner

Partner Content

Welcome to the 6th Complement-based Drug Development Summit ...

Decipher Complement Pathway Intricacies, Validate Pathway Activation Assays & Discover Next-Generation Complement-Targeted Approaches that are

News

astrazeneca-sign

AstraZeneca raises 2022 guidance, names Demaré as non-exec c...

AstraZeneca chief executive Pascal Soriot said this morning that strong revenue increases in 2022 – fuelled by its COVID-19 antibody Evusheld and oncology drugs – have allowed the company t

Market Access

euro bank notes and tablets

Orphan drugs' financial success raises questions

R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any.

Events

Erin - event listing (5)

Partner Content

2nd Integrin-Targeted Drug Development Summit

In collaboration with leading integrin drug developers, including Genentech, 7 Hills Pharm

R&D

one step forward long road

Rare Disease R&D: one step forward, but a long road ahead

With over 40% of all medicines in the pipeline aimed at rare diseases, the future looks positive for increasing the number of treatments available.

News

dollars

Rare diseases have tenfold higher impact on healthcare costs...

A new study has suggested that the economic burden posed by rare diseases is around 10 times higher than for common "mass market" conditions.